CLINAM 2020: Clinical Nanomedicine and the Impact of Digitalization and Artificial Intelligence for Precision Medicine
CLINAM, the European Foundation for Clinical Nanomedicine will celebrate on October 26 – 28, 2020 the 12th European and Global Summit for Nanomedicine with the subject Clinical Nanomedicine and the Impact of Digitalization and Artificial Intelligence for Precision Medicine. The Technologies for Diagnosis & Therapy in Patient-Centric Medicine The Conference will take place in Live Stream, due to the COVID-19 pandemic.
NANBIOSIS will participate in the Virtual Enhibition and in the poster session with a poster “Cutting Edge Biomedical Solutions in Health for Translation into Clinics”. Also Prof. Simó Schwartz, Scientific Director of NANBIOSIS U20 In vivo Experimental Platform, will give a talk about “Delivery of AntiCancer stem cell drugs in colorectal metastatic cancer” and Dr. Ibane Abasolo, Scientific Coordinator of the same Unit, will participate with a talk titled “Extracellular vesicles increase the efficacy of Enzyme Replacement Therapy in Lysosomal Storage Disorders”.
The Virtual Lounge will be available as from October 21, 2020.